Analytical Study of Probiotic Supplement in Western Europe from 2023 to 2033

The demand for probiotic supplement items in Western Europe is expected to generate a revenue of around US$ 1,038.52 million in 2023. The regional demand for probiotic supplement derived from bacteria and fungi is poised to increase at a CAGR of 8.4% between 2023 and 2033. The total value of all probiotic supplement industries in Western Europe is expected to reach US$ 2,327.12 million by 2033.

Key Trends behind the Surge in Revenues by Probiotic Supplement Industry

  • Between 2018 and 2022, the sales of the probiotic supplement industry developed at a 6.8% year-on-year growth rate and reached a valuation of US$ 966.31 million in 2023.
  • In Western Europe, the prevalence of digestive diseases results in a considerable demand for probiotic supplement, and sales are increasing through online retail channels.
  • A proactive attitude toward health and an obsession with probiotic nutrients in tablets, capsules, or gummies can be attributed to the industry's explosive growth in Western Europe.
Attributes Details
Industry Size of Western Europe in 2023 US$ 1,038.52 million
Expected Industry Size of Western Europe by 2033 US$ 2,327.12 million
Forecasted CAGR between 2023 to 2033 8.4%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Key Insights - Highlights on the Emerging Opportunities in the Western Europe Probiotic Supplement Industry

The vast culinary diversity and cultural acceptance of fermented foods in different Western European countries promote the recognition of probiotics in pure form. The growing practice of consuming probiotics supplement in simple and concentrated supplies to improve digestive health presents lucrative growth opportunities in the region.

In many Western European countries, the demand for different types of nutraceuticals and functional foods has increased significantly in recent years. The consumption of probiotic supplement is growing more swiftly as consumers recognize it to provide both nutritional and functional benefits.

Probiotic supplement are easily accessible in Western Europe due to the extensive use of eCommerce which also favors manufacturers for better reach and product visibility. By taking advantage of targeted marketing tactics and direct-to-consumer sales made possible by eCommerce websites, pharmaceutical companies have been able to develop quickly in this sector.

Category-wise insights

Women Rule the Probiotic Supplement Industry in Western Europe

The demand for probiotic supplement among women in Western Europe is estimated to make up 43.6% of the industry share in 2023.

Leading End User for Probiotic Supplement in Western Europe Women
Total Value Share (2023) 43.6%

Probiotic pills, as useful and health-improving goods, fit well into women's busy schedules and changing dietary choices during pregnancy. However, the growing adoption of probiotic supplement to help with age-related digestive problems and boost immunity is expected to drive demand in other end user segments.

Lactobacillus’ Sway over Probiotic Sphere in the Western Europe

According to the analysis report, the share of lactobacillus in the overall industry could be 37.9% in 2023.

Leading Bacteria Type for Probiotic Supplement in Western Europe Lactobacillus
Total Value Share (2023) 37.9%

Several advantages of lactobacillus for gut health are backed by scientific research, which has led to a strong demand for them in Western European countries. Since consumers consider the prevention of digestive problems as an integral element of maintaining good health, this segment has consistently retained its dominance in the region.

Nandini Roy Choudhury
Nandini Roy Choudhury

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-wise Insights

Key Countries in Western Europe Value CAGR (2023 to 2033)
Netherlands 9.1%
United Kingdom 8.5%
France 7.9%

Favorable Regulatory Frameworks are Pacing up Probiotic Supplement Industries in the Netherlands

The demand for probiotic supplement in the Netherlands is forecasted to develop at 9.1% CAGR during the projected timeline.

The regulatory framework in place for the use of probiotic supplement by food and beverage industries fosters customer trust and is anticipated to promote and expedite the industry's growth. For example, the Netherlands Food and Drug Administration published guidelines in March 2021 to mention "probiotics" as essential data on food and supplement labels.

Well-Informed Consumers in the United Kingdom are Driving the Industry in the United Kingdom

Over the forecasted years, the sales of probiotic supplement in the United Kingdom are projected to rise at 8.5% CAGR.

Producers of probiotic supplement in the United Kingdom have the advantage of a consumer base with a better understanding of the unique health benefits of their goods. Moreover, many probiotic supplement have established international supply chains that could play a pivotal role in the further growth of the industry.

Probiotic Supplement Suppliers in France are Emphasizing Promotional Activities

The probiotic supplement industry in France is anticipated to expand at a 7.9% compound annual growth rate per year between 2023 and 2033.

In France, consumers are significantly influenced by the endorsements, testimonies, and suggestions of health experts regarding the use of supplement and functional foods. So, probiotic supplement suppliers in the country are using targeted advertisement and instructional initiatives to create an atmosphere that is favorable for their products.

Competitive Landscape

The probiotic supplement industry in Western Europe is highly concentrated, with a few dominant companies including Nestle, BioGaia, and Sinbiotic holding a significant revenue share. In recent years, these leading players have further solidified their places by releasing consumer-oriented products in packaged form. On the other hand, smaller companies in this sector have prioritized probiotic research and innovations to serve a diverse clientele and enhance their brand recognition.

Recent Developments by Probiotic Supplement Industries in Western Europe

In May 2023, Roquette expanded the health and nutrition industry toward a more flexible, reliable, and consumer-focused future for probiotic supplement with the introduction of PEARLITOL® ProTec. This new excipient is a novel plant-based co-processed combination of mannitol and maize starch which stabilizes and extends the shelf life of active probiotics that are sensitive to moisture.

In August 2022, BioGaia Campany declared to add new bacterial strains to its product lineup, which it would be developing in partnership with its subsidiary MetaboGen. The two companies are also working together to construct a fermentation pilot facility in Eslöv to develop these novel strains through clinical trials.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Some of the Key Players Offering Probiotic Supplement in Western Europe

  • Alphanova (France)
  • Altaïcare (France)
  • Arkopharma (France)
  • Arla Foods (Denmark)
  • Atida Sweden (Sweden)
  • BioGaia (Sweden)
  • Danone (France)
  • Dr. Willmar Schwabe (Germany)
  • Embark Holdings (United Kingdom)
  • Galderma (Switzerland)
  • GlaxoSmithKline (United Kingdom)
  • Herbapol (Poland)
  • Hero Group (Spain)
  • Holland & Barrett (United Kingdom)
  • Innova Biosciences (Spain)
  • Kerry Group (Ireland)
  • Nestlé (Switzerland)
  • New Nordic (Denmark)
  • Nutraingredients (United Kingdom)
  • Orkla Health (Norway)
  • Pharma Nord (Denmark)
  • Procter & Gamble (United States)
  • Proderna (Belgium)
  • Provita (Spain)
  • Qiagen (Germany)
  • Reckitt Benckiser (United Kingdom)
  • Synbiotic International (United Kingdom)
  • Valio (Finland)
  • Vitabiotics (United Kingdom)
  • Wessanen (Netherlands)

Scope of the Report

Attribute Details
Estimated Industry Size in 2023 US$ 1,038.52 million
Projected Industry Size by 2033 US$ 2,327.12 million
Anticipated CAGR between 2023 to 2033 8.4% CAGR
Historical Analysis of Demand for Probiotic Supplement in Western Europe 2018 to 2022
Demand Forecast for Probiotic Supplement in Western Europe 2023 to 2033
Report Coverage Industry Size, Industry Trends, Analysis of key factors influencing Probiotic Supplement Adoption in Western Europe, Insights on Global Players and their Industry Strategy in Western Europe, Ecosystem Analysis of Local and Regional Western Europe Manufacturers
Key Countries Analyzed while Studying Opportunities in Probiotic Supplement in Western Europe Germany, Italy, France, Spain, United Kingdom, BENELUX, Rest of Western Europe
Key Companies Profiled Alphanova (France); Altaïcare (France); Arkopharma (France); Arla Foods (Denmark); Atida Sweden (Sweden); BioGaia (Sweden); Danone (France); Dr. Willmar Schwabe (Germany); Embark Holdings (United Kingdom); Galderma (Switzerland); GlaxoSmithKline (United Kingdom); Herbapol (Poland); Hero Group (Spain); Holland & Barrett (United Kingdom); Innova Biosciences (Spain); Kerry Group (Ireland); Nestlé (Switzerland); New Nordic (Denmark); Nutraingredients (United Kingdom); Orkla Health (Norway); Pharma Nord (Denmark); Procter & Gamble (United States); Proderna (Belgium); Provita (Spain); Qiagen (Germany); Reckitt Benckiser (United Kingdom); Synbiotic International (United Kingdom); Valio (Finland); Vitabiotics (United Kingdom); Wessanen (Netherlands)

Key Segments Covered in Western Europe Probiotic Supplement Industry Survey

By Bacteria:

  • Lactobacillus
  • Streptococcus
  • Bifidobacterium

By Form:

  • Tablet
  • Capsules
  • Liquid
  • Powder Premixes
  • Gummies/Chewable
  • Lozenges
  • Liquid & Gels

By Function:

  • Immunity & Digestive Health
  • Urogenital Health
  • Vaginal Health
  • Urinary Tract Infections
  • Pregnancy
  • Weight Management

By Distribution Channel:

  • Hypermarket/ Supermarket
  • Specialty Stores
  • eCommerce
  • Pharmacy Stores

By End User:

  • Women
  • Seniors
  • Kids

By Country:

  • Germany
  • Italy
  • France
  • Spain
  • United Kingdom
  • BENELUX
  • Rest of Western Europe

Frequently Asked Questions

How Rapidly is the Western Europe Probiotic Supplement Industry likely to Grow?

The expected CAGR for the industry in Western Europe through 2033 is 8.4%.

What is the Demand Outlook for Probiotic Supplement in Western Europe?

The anticipated demand in Western Europe is likely to reach US$ 2,327.12 million by 2033.

Which Trends have influenced the Probiotic Supplement Industry in the Region?

The rising popularity of supplement in chewable form has impacted the regional sales.

What Strategies are used by Probiotic Supplement Providers in Western Europe?

Probiotic supplement manufacturers are emphasizing more on promotional activities.

Which End User Segment is Driving Probiotic Supplement Industry in Western Europe?

Women are set to account for 43.6% of overall demand across Western Europe in 2023.

Table of Content
1. Executive Summary
    1.1. Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Product Life Cycle Analysis
    3.5. Supply Chain Analysis
        3.5.1. Supply Side Participants and their Roles
            3.5.1.1. Producers
            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
            3.5.1.3. Wholesalers and Distributors
        3.5.2. Value Added and Value Created at Node in the Supply Chain
        3.5.3. List of Raw Material Suppliers
        3.5.4. List of Existing and Potential Buyer’s
    3.6. Investment Feasibility Matrix
    3.7. Value Chain Analysis
        3.7.1. Profit Margin Analysis
        3.7.2. Wholesalers and Distributors
        3.7.3. Retailers
    3.8. PESTLE and Porter’s Analysis
    3.9. Regulatory Landscape
        3.9.1. By Key Regions
        3.9.2. By Key Countries
    3.10. Regional Parent Market Outlook
    3.11. Production and Consumption Statistics
    3.12. Import and Export Statistics
4. Industry Analysis and Outlook 2018 to 2022 and Forecast, 2023 to 2033
    4.1. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis, 2018 to 2022
    4.2. Current and Future Market Size Value (US$ Million) & Volume (Tons) Projections, 2023 to 2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Bacteria
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Bacteria, 2018 to 2022
    5.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Bacteria, 2023 to 2033
        5.3.1. Lactobacillus
        5.3.2. Streptococcus
        5.3.3. Bifid bacterium
    5.4. Y-o-Y Growth Trend Analysis By Bacteria, 2018 to 2022
    5.5. Absolute $ Opportunity Analysis By Bacteria, 2023 to 2033
6. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Form
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Form, 2018 to 2022
    6.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Form, 2023 to 2033
        6.3.1. Tablet
        6.3.2. Capsules
        6.3.3. Liquid
        6.3.4. Powder Premixes
        6.3.5. Gummies/Chewable
        6.3.6. Lozenges
        6.3.7. Liquid & Gels
    6.4. Y-o-Y Growth Trend Analysis By Form, 2018 to 2022
    6.5. Absolute $ Opportunity Analysis By Form, 2023 to 2033
7. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Function
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Function, 2018 to 2022
    7.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Function, 2023 to 2033
        7.3.1. Immunity & Digestive Health
        7.3.2. Urogenital Health
        7.3.3. Vaginal Health
        7.3.4. Urinary Tract Infections
        7.3.5. Pregnancy
        7.3.6. Weight Management
    7.4. Y-o-Y Growth Trend Analysis By Function, 2018 to 2022
    7.5. Absolute $ Opportunity Analysis By Function, 2023 to 2033
8. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
    8.1. Introduction / Key Findings
    8.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Distribution Channel, 2018 to 2022
    8.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Distribution Channel, 2023 to 2033
        8.3.1. Hypermarket/ Supermarket
        8.3.2. Specialty Stores
        8.3.3. E-Commerce
        8.3.4. Pharmacy Stores
    8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022
    8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033
9. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By End User
    9.1. Introduction / Key Findings
    9.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By End User, 2018 to 2022
    9.3. Current and Future Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By End User, 2023 to 2033
        9.3.1. Women
        9.3.2. Seniors
        9.3.3. Kids
    9.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
    9.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
10. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Country
    10.1. Introduction
    10.2. Historical Market Size Value (US$ Million) & Volume (Tons) Analysis By Country, 2018 to 2022
    10.3. Current Market Size Value (US$ Million) & Volume (Tons) Analysis and Forecast By Country, 2023 to 2033
        10.3.1. UK
        10.3.2. Germany
        10.3.3. Italy
        10.3.4. France
        10.3.5. Spain
        10.3.6. Rest of Western Europe
    10.4. Market Attractiveness Analysis By Country
11. UK Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
    11.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
    11.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033
        11.2.1. By Region
            11.2.1.1. England
            11.2.1.2. Scotland
            11.2.1.3. Wales
            11.2.1.4. Northern Ireland
        11.2.2. By Bacteria
        11.2.3. By Form
        11.2.4. By Function
        11.2.5. By Distribution Channel
        11.2.6. By End User
    11.3. Market Attractiveness Analysis
        11.3.1. By Region
        11.3.2. By Bacteria
        11.3.3. By Form
        11.3.4. By Function
        11.3.5. By Distribution Channel
        11.3.6. By End User
    11.4. Key Takeaways
12. Germany Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
    12.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
    12.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033
        12.2.1. By Region
            12.2.1.1. North-east (Germany)
            12.2.1.2. North-west (Germany)
            12.2.1.3. Central (Germany)
            12.2.1.4. South (Germany)
            12.2.1.5. Other(Germany)
        12.2.2. By Bacteria
        12.2.3. By Form
        12.2.4. By Function
        12.2.5. By Distribution Channel
        12.2.6. By End User
    12.3. Market Attractiveness Analysis
        12.3.1. By Region
        12.3.2. By Bacteria
        12.3.3. By Form
        12.3.4. By Function
        12.3.5. By Distribution Channel
        12.3.6. By End User
    12.4. Key Takeaways
13. Italy Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
    13.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
    13.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033
        13.2.1. By Region
            13.2.1.1. North (Italy)
            13.2.1.2. Central (Italy)
            13.2.1.3. South (Italy)
            13.2.1.4. Islands (Italy)
        13.2.2. By Bacteria
        13.2.3. By Form
        13.2.4. By Function
        13.2.5. By Distribution Channel
        13.2.6. By End User
    13.3. Market Attractiveness Analysis
        13.3.1. By Region
        13.3.2. By Bacteria
        13.3.3. By Form
        13.3.4. By Function
        13.3.5. By Distribution Channel
        13.3.6. By End User
    13.4. Key Takeaways
14. France Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
    14.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
    14.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033
        14.2.1. By Region
            14.2.1.1. Northern (France)
            14.2.1.2. Central (France)
            14.2.1.3. Southern (France)
            14.2.1.4. Eastern (France)
        14.2.2. By Bacteria
        14.2.3. By Form
        14.2.4. By Function
        14.2.5. By Distribution Channel
        14.2.6. By End User
    14.3. Market Attractiveness Analysis
        14.3.1. By Region
        14.3.2. By Bacteria
        14.3.3. By Form
        14.3.4. By Function
        14.3.5. By Distribution Channel
        14.3.6. By End User
    14.4. Key Takeaways
15. Spain Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
    15.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
    15.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033
        15.2.1. By Region
            15.2.1.1. Basque Country
            15.2.1.2. Andalusia
            15.2.1.3. Extremadura
            15.2.1.4. Catalonia
            15.2.1.5. Valencia
            15.2.1.6. Rest of Spain
        15.2.2. By Bacteria
        15.2.3. By Form
        15.2.4. By Function
        15.2.5. By Distribution Channel
        15.2.6. By End User
    15.3. Market Attractiveness Analysis
        15.3.1. By Region
        15.3.2. By Bacteria
        15.3.3. By Form
        15.3.4. By Function
        15.3.5. By Distribution Channel
        15.3.6. By End User
    15.4. Key Takeaways
16. Rest of Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
    16.1. Historical Market Size Value (US$ Million) & Volume (Tons) Trend Analysis By Market Taxonomy, 2018 to 2022
    16.2. Market Size Value (US$ Million) & Volume (Tons) Forecast By Market Taxonomy, 2023 to 2033
        16.2.1. By Bacteria
        16.2.2. By Form
        16.2.3. By Function
        16.2.4. By Distribution Channel
        16.2.5. By End User
    16.3. Market Attractiveness Analysis
        16.3.1. By Bacteria
        16.3.2. By Form
        16.3.3. By Function
        16.3.4. By Distribution Channel
        16.3.5. By End User
    16.4. Key Takeaways
17. Market Structure Analysis
    17.1. Competition Dashboard
    17.2. Competition Benchmarking
    17.3. Market Share Analysis of Top Players
        17.3.1. By Regional
        17.3.2. By Bacteria
        17.3.3. By Form
        17.3.4. By Function
        17.3.5. By Distribution Channel
        17.3.6. By End User
18. Competition Analysis
    18.1. Competition Deep Dive
        18.1.1. Bio-Kult
            18.1.1.1. Overview
            18.1.1.2. Product Portfolio
            18.1.1.3. Profitability by Market Segments
            18.1.1.4. Sales Footprint
            18.1.1.5. Strategy Overview
                18.1.1.5.1. Marketing Strategy
                18.1.1.5.2. Product Strategy
                18.1.1.5.3. Channel Strategy
        18.1.2. Optibac Probiotics
            18.1.2.1. Overview
            18.1.2.2. Product Portfolio
            18.1.2.3. Profitability by Market Segments
            18.1.2.4. Sales Footprint
            18.1.2.5. Strategy Overview
                18.1.2.5.1. Marketing Strategy
                18.1.2.5.2. Product Strategy
                18.1.2.5.3. Channel Strategy
        18.1.3. Symprove
            18.1.3.1. Overview
            18.1.3.2. Product Portfolio
            18.1.3.3. Profitability by Market Segments
            18.1.3.4. Sales Footprint
            18.1.3.5. Strategy Overview
                18.1.3.5.1. Marketing Strategy
                18.1.3.5.2. Product Strategy
                18.1.3.5.3. Channel Strategy
        18.1.4. ProVen Probiotics
            18.1.4.1. Overview
            18.1.4.2. Product Portfolio
            18.1.4.3. Profitability by Market Segments
            18.1.4.4. Sales Footprint
            18.1.4.5. Strategy Overview
                18.1.4.5.1. Marketing Strategy
                18.1.4.5.2. Product Strategy
                18.1.4.5.3. Channel Strategy
        18.1.5. Sanofi.
            18.1.5.1. Overview
            18.1.5.2. Product Portfolio
            18.1.5.3. Profitability by Market Segments
            18.1.5.4. Sales Footprint
            18.1.5.5. Strategy Overview
                18.1.5.5.1. Marketing Strategy
                18.1.5.5.2. Product Strategy
                18.1.5.5.3. Channel Strategy
        18.1.6. Jarrow Formulas
            18.1.6.1. Overview
            18.1.6.2. Product Portfolio
            18.1.6.3. Profitability by Market Segments
            18.1.6.4. Sales Footprint
            18.1.6.5. Strategy Overview
                18.1.6.5.1. Marketing Strategy
                18.1.6.5.2. Product Strategy
                18.1.6.5.3. Channel Strategy
        18.1.7. NOVA Probiotics
            18.1.7.1. Overview
            18.1.7.2. Product Portfolio
            18.1.7.3. Profitability by Market Segments
            18.1.7.4. Sales Footprint
            18.1.7.5. Strategy Overview
                18.1.7.5.1. Marketing Strategy
                18.1.7.5.2. Product Strategy
                18.1.7.5.3. Channel Strategy
        18.1.8. Lifeway Foods
            18.1.8.1. Overview
            18.1.8.2. Product Portfolio
            18.1.8.3. Profitability by Market Segments
            18.1.8.4. Sales Footprint
            18.1.8.5. Strategy Overview
                18.1.8.5.1. Marketing Strategy
                18.1.8.5.2. Product Strategy
                18.1.8.5.3. Channel Strategy
        18.1.9. Total Nutrition, Inc.
            18.1.9.1. Overview
            18.1.9.2. Product Portfolio
            18.1.9.3. Profitability by Market Segments
            18.1.9.4. Sales Footprint
            18.1.9.5. Strategy Overview
                18.1.9.5.1. Marketing Strategy
                18.1.9.5.2. Product Strategy
                18.1.9.5.3. Channel Strategy
        18.1.10. Pharma Care Laboratories
            18.1.10.1. Overview
            18.1.10.2. Product Portfolio
            18.1.10.3. Profitability by Market Segments
            18.1.10.4. Sales Footprint
            18.1.10.5. Strategy Overview
                18.1.10.5.1. Marketing Strategy
                18.1.10.5.2. Product Strategy
                18.1.10.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Recommendations

Food and Beverage

Probiotic Supplement Market

March 2024

REP-GB-613

369 pages

Food and Beverage

Probiotic Yogurt Market

March 2023

REP-GB-3259

342 pages

Food and Beverage

Probiotic Fermented Milk Market

October 2022

REP-GB-3257

250 pages

Explore Food and Beverage Insights

View Reports
Future Market Insights

Demand and Trend Analysis of Probiotic Supplement in Western Europe

Schedule a Call